Merck Valuation
| MRK Stock | EUR 143.95 0.10 0.07% |
At this time, the firm appears to be fairly valued. Merck Company secures a last-minute Real Value of €148.29 per share. The latest price of the firm is €143.95. Our model forecasts the value of Merck Company from analyzing the firm fundamentals such as Profit Margin of 0.16 %, return on equity of 0.14, and Current Valuation of 87.36 B as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Merck's price fluctuation is very steady at this time. Calculation of the real value of Merck Company is based on 3 months time horizon. Increasing Merck's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Merck stock is determined by what a typical buyer is willing to pay for full or partial control of Merck Company. Since Merck is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Merck Stock. However, Merck's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 143.95 | Real 148.29 | Hype 143.95 |
The real value of Merck Stock, also known as its intrinsic value, is the underlying worth of Merck Company Company, which is reflected in its stock price. It is based on Merck's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Merck's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Merck Company helps investors to forecast how Merck stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Merck more accurately as focusing exclusively on Merck's fundamentals will not take into account other important factors: Merck Total Value Analysis
Merck Company is now estimated to have takeover price of 87.36 B with market capitalization of 73.82 B, debt of 7.93 B, and cash on hands of 2.3 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Merck fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
87.36 B | 73.82 B | 7.93 B | 2.3 B |
Merck Investor Information
About 60.0% of the company shares are owned by institutional investors. The book value of Merck was now reported as 64.91. The company recorded earning per share (EPS) of 7.99. Merck Company last dividend was issued on the 25th of April 2022. The entity had 2:1 split on the 30th of June 2014. Merck Company is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Merck Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Merck has an asset utilization ratio of 43.4 percent. This implies that the Company is making €0.43 for each dollar of assets. An increasing asset utilization means that Merck Company is more efficient with each dollar of assets it utilizes for everyday operations.Merck Ownership Allocation
Merck Company maintains a total of 129.24 Million outstanding shares. Over half of Merck's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Merck Company. Please watch out for any change in the institutional holdings of Merck Company as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Merck Profitability Analysis
The company reported the revenue of 19.69 B. Net Income was 3.06 B with profit before overhead, payroll, taxes, and interest of 12.36 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Merck's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Merck and how it compares across the competition.
About Merck Valuation
The stock valuation mechanism determines Merck's current worth on a weekly basis. Our valuation model uses a comparative analysis of Merck. We calculate exposure to Merck's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Merck's related companies.MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. MERCK KGAA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 57850 people.
8 Steps to conduct Merck's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Merck's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Merck's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Merck's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Merck's revenue streams: Identify Merck's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Merck's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Merck's growth potential: Evaluate Merck's management, business model, and growth potential.
- Determine Merck's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Merck's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Merck Stock analysis
When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |